| Mr Michael Jon Kirwan, CRNA | |
|
810 North 22nd Street, Blair, NE 68008-1128 | |
| (402) 426-2182 | |
| (402) 426-1297 |
| Full Name | Mr Michael Jon Kirwan |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 35 Years |
| Location | 810 North 22nd Street, Blair, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316931074 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 100955 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Leighow Anesthesia And Medical Aesthetics Llc | 5597086744 | 14 |
| Midwest Gastrointestinal Associates Pc | 3779575766 | 46 |
News Archive
An individual's trust in institutions such as the CDC, and how close they live to a recent measles outbreak, may affect their attitudes on measles vaccination, according to a study published August 28, 2019 in the open-access journal PLOS ONE by Florian Justwan of the University of Idaho, USA, and colleagues.
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth.
AU Optronics Corp. ("AUO" or the "Company") announced today that it will participate in Display Week 2014 in San Diego from June 3 to 5. Organized by SID (The Society for Information Display), Display Week is the largest professional display exhibition in the United States.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, launched its suite of digital pathology solutions in Europe. The company will showcase these digital pathology solutions at the Woche der Pathologie Congress in Berlin, which takes place from May 27-30, 2010.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by Alnylam scientists and collaborators from Mount Sinai School of Medicine. In the new study, Alnylam and Mount Sinai scientists discovered a novel class of virus-produced small non-coding RNAs, called small viral RNAs (svRNAs), which play a critical role in the replication of influenza A virus.
› Verified 8 days ago
| Entity Name | Midwest Gastrointestinal Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073569125 PECOS PAC ID: 3779575766 Enrollment ID: O20040402000222 |
News Archive
An individual's trust in institutions such as the CDC, and how close they live to a recent measles outbreak, may affect their attitudes on measles vaccination, according to a study published August 28, 2019 in the open-access journal PLOS ONE by Florian Justwan of the University of Idaho, USA, and colleagues.
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth.
AU Optronics Corp. ("AUO" or the "Company") announced today that it will participate in Display Week 2014 in San Diego from June 3 to 5. Organized by SID (The Society for Information Display), Display Week is the largest professional display exhibition in the United States.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, launched its suite of digital pathology solutions in Europe. The company will showcase these digital pathology solutions at the Woche der Pathologie Congress in Berlin, which takes place from May 27-30, 2010.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by Alnylam scientists and collaborators from Mount Sinai School of Medicine. In the new study, Alnylam and Mount Sinai scientists discovered a novel class of virus-produced small non-coding RNAs, called small viral RNAs (svRNAs), which play a critical role in the replication of influenza A virus.
› Verified 8 days ago
| Entity Name | Leighow Anesthesia & Medical Aesthetics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376936112 PECOS PAC ID: 5597086744 Enrollment ID: O20150601000518 |
News Archive
An individual's trust in institutions such as the CDC, and how close they live to a recent measles outbreak, may affect their attitudes on measles vaccination, according to a study published August 28, 2019 in the open-access journal PLOS ONE by Florian Justwan of the University of Idaho, USA, and colleagues.
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth.
AU Optronics Corp. ("AUO" or the "Company") announced today that it will participate in Display Week 2014 in San Diego from June 3 to 5. Organized by SID (The Society for Information Display), Display Week is the largest professional display exhibition in the United States.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, launched its suite of digital pathology solutions in Europe. The company will showcase these digital pathology solutions at the Woche der Pathologie Congress in Berlin, which takes place from May 27-30, 2010.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by Alnylam scientists and collaborators from Mount Sinai School of Medicine. In the new study, Alnylam and Mount Sinai scientists discovered a novel class of virus-produced small non-coding RNAs, called small viral RNAs (svRNAs), which play a critical role in the replication of influenza A virus.
› Verified 8 days ago
| Entity Name | Metro Omaha Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558884072 PECOS PAC ID: 1456626050 Enrollment ID: O20171009000112 |
News Archive
An individual's trust in institutions such as the CDC, and how close they live to a recent measles outbreak, may affect their attitudes on measles vaccination, according to a study published August 28, 2019 in the open-access journal PLOS ONE by Florian Justwan of the University of Idaho, USA, and colleagues.
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth.
AU Optronics Corp. ("AUO" or the "Company") announced today that it will participate in Display Week 2014 in San Diego from June 3 to 5. Organized by SID (The Society for Information Display), Display Week is the largest professional display exhibition in the United States.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, launched its suite of digital pathology solutions in Europe. The company will showcase these digital pathology solutions at the Woche der Pathologie Congress in Berlin, which takes place from May 27-30, 2010.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by Alnylam scientists and collaborators from Mount Sinai School of Medicine. In the new study, Alnylam and Mount Sinai scientists discovered a novel class of virus-produced small non-coding RNAs, called small viral RNAs (svRNAs), which play a critical role in the replication of influenza A virus.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Jon Kirwan, CRNA 20803 Hemlock St, Elkhorn, NE 68022-5119 Ph: (402) 380-0869 | Mr Michael Jon Kirwan, CRNA 810 North 22nd Street, Blair, NE 68008-1128 Ph: (402) 426-2182 |
News Archive
An individual's trust in institutions such as the CDC, and how close they live to a recent measles outbreak, may affect their attitudes on measles vaccination, according to a study published August 28, 2019 in the open-access journal PLOS ONE by Florian Justwan of the University of Idaho, USA, and colleagues.
About 30% of breast cancer patients have tumours that show rapid growth and invasion through the body. A common denominator in all of these cases is the presence of a large number of Her2 proteins in tumour cellular membranes. Consequently, these aggressive tumours are referred to as HER2+. Scientists working in the Metastasis Laboratory (MetLab) at IRB Barcelona headed by ICREA researcher Roger Gomis, have described the molecular mechanism that induces HER2+ tumours to ignore the signals that protect cells from excessive growth.
AU Optronics Corp. ("AUO" or the "Company") announced today that it will participate in Display Week 2014 in San Diego from June 3 to 5. Organized by SID (The Society for Information Display), Display Week is the largest professional display exhibition in the United States.
BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, launched its suite of digital pathology solutions in Europe. The company will showcase these digital pathology solutions at the Woche der Pathologie Congress in Berlin, which takes place from May 27-30, 2010.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by Alnylam scientists and collaborators from Mount Sinai School of Medicine. In the new study, Alnylam and Mount Sinai scientists discovered a novel class of virus-produced small non-coding RNAs, called small viral RNAs (svRNAs), which play a critical role in the replication of influenza A virus.
› Verified 8 days ago
Tony Tran, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 810 N 22nd St, Blair, NE 68008 Phone: 402-426-2182 Fax: 402-426-1181 | |
Allan C Merit, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 810 N 22nd St, Blair, NE 68008 Phone: 402-426-2182 | |
Jessica Thurlow, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11154 County Road 19, Blair, NE 68008 Phone: 402-719-7325 | |
Michael W. Suing, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 810 N 22nd St, Blair, NE 68008 Phone: 402-426-2182 Fax: 402-426-1181 |